Month: May 2020

OKLAHOMA CITY, May 19, 2020 (GLOBE NEWSWIRE) — Devon Energy Corp. (NYSE: DVN) today announced a change in the time and format for its 2020 Annual Meeting of Stockholders. Because of continued concerns about the COVID-19 pandemic, the Annual Meeting will be held solely by remote communication, in a “virtual-only” format. The previously announced date of June 3, 2020, has not changed, but the meeting will now take place at 1 p.m. Central Time (CT) rather than 8 a.m. CT. As a safety precaution, the Devon Energy Center, including the Devon Energy Center Auditorium where the meeting was to occur, remains closed to the public until further notice. The meeting will be webcast and can be accessed by stockholders at www.virtualshareholdermeeting.com/DVN2020 using the control number on their proxy card, voting instruction form or Notice of...

CHATTANOOGA, Tenn., May 19, 2020 (GLOBE NEWSWIRE) — Covenant Transportation Group, Inc.  (NASDAQ/GS: CVTI) (“CTG”) announced today financial and operating results for the first quarter ended March 31, 2020.Highlights for the quarter included the following:Total revenue of $213.6 million, a decrease of 2.6% compared with the first quarter of 2019.Freight revenue of $192.3 million (excludes revenue from fuel surcharges), a decrease of 1.8% compared with the first quarter of 2019.Operating income of $0.7 million and an operating ratio of 99.7%. Adjusted operating income(1) of $1.4 million and an adjusted operating ratio(1) of 99.3%. This compares with operating income of $5.4 million and an operating ratio of 97.5% and adjusted operating income(1) of $6.2 million and an adjusted operating ratio(1) of 96.9% in the first quarter of 2019.Net...

Clinical Studies Re-Opened to New Patient Enrollment Following Temporary Pause Due to COVID-19 PandemicNumerous Clinical Data Announcements Expected in 2020Cash and Cash Equivalents Expected to Fund Operations At Least into the Fourth Quarter of 2021EDINBURGH, United Kingdom, May 19, 2020 (GLOBE NEWSWIRE) — NuCana plc (NASDAQ: NCNA) announced financial results for the first quarter ended March 31, 2020 and provided an update on its broad clinical program with its transformative ProTide therapeutics.As of March 31, 2020, NuCana had cash and cash equivalents of £47.6 million compared to £52.0 million as of December 31, 2019. NuCana continues to advance its various clinical programs and reported a net loss of £4.0 million for the quarter ended March 31, 2020, as compared to £5.4 million for the quarter ended March 31, 2019. Basic and...

CAMBRIDGE, Mass., May 19, 2020 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (NASDAQ: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body, provided a business update for the first quarter 2020.“We have successfully maintained momentum in meeting our business goals and clinical trial objectives for the first quarter and early second quarter of 2020, despite the rapid onset of COVID-19 and the many challenges it has presented,” said Daniel Passeri, chief executive officer of Cue Biopharma. “I am grateful for the dedication of the Cue Biopharma team during this pandemic as we continue to work together and safely execute on our mission of bringing novel therapies to patients with serious diseases.”According to Kerri-Ann Millar,...